CIC
NUVB icon

Cornercap Investment Counsel’s Nuvation Bio NUVB Stock Holding History

Cornercap Investment Counsel’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,811
Closed -$59.1K – 515
2024
Q3 		$59.1K Sell
25,811
-29,698
-54% -$90.6K 0.02% 503
2024
Q2 		$162K Sell
55,509
-62,548
-53% -$191K 0.03% 551
2024
Q1 		$430K Hold
118,057
– – 0.07% 485
2023
Q4 		$178K Hold
118,057
– – 0.03% 540
2023
Q3 		$158K Sell
118,057
-1,228
-1% -$2.04K 0.03% 508
2023
Q2 		$215K Hold
119,285
– – 0.04% 501
2023
Q1 		$198K Hold
119,285
– – 0.03% 505
2022
Q4 		$229K Buy
119,285
+43,356
+57% +$87.7K 0.04% 504
2022
Q3 		$170K Buy
+75,929
New +$217K 0.03% 508

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Cornercap Investment Counsel's NUVB Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 25,811 shares — an estimated $59.1K sold.

Cornercap Investment Counsel first reported a position in NUVB in Q3 2022 and held it in 9 quarters. The position peaked at $430K in Q1 2024. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 25,811 Nuvation Bio shares in Q4 2024, an estimated $59.1K.
  • Cornercap Investment Counsel first reported a position in Nuvation Bio in Q3 2022 and held it in 9 quarters.
  • Cornercap Investment Counsel's Nuvation Bio position peaked at $430K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.